Delving into Stem Cell Research and its Potential 2018
Stem cells are primal cells found in all multi-cellular organisms that retain the ability to renew themselves through mitotic cell division and can differentiate into a wide range of specialized cell types.
As stem cells can be readily grown and transformed into specialized cells with characteristics consistent with cells of various tissues such as muscles or nerves through cell culture, their use in medical therapies has been proposed. In particular, embryonic cell lines, autologous embryonic stem cells generated through therapeutic cloning, and highly plastic adult stem cells from the umbilical cord blood or bone marrow are touted as promising candidates.
There exists a widespread controversy over stem cell research that emanates from the techniques used in the creation and usage of stem cells. Human embryonic stem cell research is particularly controversial because, with the present state of technology, starting a stem cell line requires the destruction of a human embryo and/or therapeutic cloning.
Aruvian Research brings you an entire in-depth study of a very niche subject in the wide field of stem cells – Stem Cell Research and its Potential 2018. The report looks at the various types of stem cells which exist and the different benefits each of them offer. The much-talked about embryonic stem cell research and adult stem cell research is discussed in-depth in the report. A separate section covers all the medical uses of stem cell research as well as exploring the potential of stem cell research and therapies.
Challenges, barriers, benefits of stem cells, a look at the global approach to stem cell research, and an analysis of the leading players in this industry are what make this report a must-have!
As stem cells can be readily grown and transformed into specialized cells with characteristics consistent with cells of various tissues such as muscles or nerves through cell culture, their use in medical therapies has been proposed. In particular, embryonic cell lines, autologous embryonic stem cells generated through therapeutic cloning, and highly plastic adult stem cells from the umbilical cord blood or bone marrow are touted as promising candidates.
There exists a widespread controversy over stem cell research that emanates from the techniques used in the creation and usage of stem cells. Human embryonic stem cell research is particularly controversial because, with the present state of technology, starting a stem cell line requires the destruction of a human embryo and/or therapeutic cloning.
Aruvian Research brings you an entire in-depth study of a very niche subject in the wide field of stem cells – Stem Cell Research and its Potential 2018. The report looks at the various types of stem cells which exist and the different benefits each of them offer. The much-talked about embryonic stem cell research and adult stem cell research is discussed in-depth in the report. A separate section covers all the medical uses of stem cell research as well as exploring the potential of stem cell research and therapies.
Challenges, barriers, benefits of stem cells, a look at the global approach to stem cell research, and an analysis of the leading players in this industry are what make this report a must-have!
A. EXECUTIVE SUMMARY
B. INTRODUCTION TO STEM CELLS
B.1 What are Stem Cells?
B.2 Categories of Stem Cells
B.2.1 Totipotent Stem Cells
B.2.2 Multipotent Stem Cells
B.2.3 Pluripotent Stem Cells
B.3 Where do Stem Cells Come From?
B.4 Importance of Stem Cells
B.5 Stem Cell Research vs. Cloning
C. LOOKING INTO STEM CELL RESEARCH
C.1 Embryonic Stem Cell Research
C.2 Adult Stem Cell Research
C.3 Limitation of Stem Cell Therapies by Immune Rejection
D. POTENTIAL OF STEM CELL RESEARCH & THERAPIES
D.1 ES Cells for Tissue Repair
D.2 Generic ES Cell
D.3 Adult Stem Cell Therapies
D.4 Therapeutic Cloning
E. BENEFITS OF STEM CELL THERAPIES
F. BARRIERS & CHALLENGES IN STEM CELL RESEARCH
F.1 Ethical Issues
F.2 Moral Issues
F.3 Issues Surrounding Embryo Destruction
F.4 Issues Surrounding Cloning
F.5 Funding & Economic Issues
F.6 Intellectual Property Challenges
F.7 Justice Issues
F.8 Lack of Accountability
F.9 Private Sector Lapses
F.10 Public Sector Lapses
F.11 Religious Issues
G. STEM CELL IN MEDICAL USE
G.1 Blood Disorders
G.2 Cancer
G.3 Diseases of Bone and Cartilage
G.4 Nervous System Diseases
G.5 Primary Immunodeficiency Diseases
G.6 Toxicity and Drug Testing
G.7 Transplantable Organs
G.8 Type 1 Diabetes in Children
H. TRENDS IN THE INDUSTRY
H.1 Variations in the Source of Stem Cells
H.2 Application in the Pharmaceutical Industry
H.3 Creation of Human-Animal Hybrid Embryos
H.4 Stem Cells for the Treatment of Heart Disease
I. FUNDING FOR STEM CELL RESEARCH
I.1 History of Embryo Research Funding
I.2 US Politics and the Stem Cells Industry
I.3 Moral Issues Affecting the Policy
I.4 Significance & Requirement of Federal Funding
I.5 Implementing the Current Policy
I.6 Conclusion
J. GLOBAL APPROACH TO HUMAN STEM CELL RESEARCH
J.1 Australia
J.2 European Union
J.3 United Kingdom
J.4 United States
J.5 Canada
J.6 China
J.7 Germany
J.8 Israel
J.9 Japan
K. INDUSTRY OUTLOOK
L. LEADING PLAYERS IN STEM CELL RESEARCH
L.1 AlloSource, Inc.
L.2 Amgen
L.3 Anterogen
L.4 Apceth Biopharma
L.5 Astellas Pharma
L.6 Athersys
L.7 Biomagnetics Diagnostics Corporation
L.8 BioTime, Inc.
L.9 BrainStorm Cell Therapeutics
L.10 Caladrius Biosciences Inc
L.11 Celyad SA
L.12 Cesca Therapeutics
L.13 Cryo-Cell International
L.14 Cynata Therapeutics Limited
L.15 CytoGenix, Inc.
L.16 Cytori Therapeutics Inc
L.17 Gamida Cell Ltd.
L.18 Geron Corporation
L.19 International Stem Cell Corporation (ISCO)
L.20 Medipost
L.21 Mesoblast Limited
L.22 Microbot Medical Inc.
L.23 Microchip Technology Inc.
L.24 Neuralstem Inc.
L.25 Neuralstem, Inc.
L.26 Osiris Therapeutics, Inc.
L.27 Pharmicell Inc.
L.28 Pluristem Therapeutics
L.29 Quest Diagnostics
L.30 Regeneus Ltd
L.31 Reliance Life Sciences
L.32 ReNeuron
L.33 Stempeutics Research
L.34 Tigenix NV
L.35 Transition Therapeutics Inc.
L.36 U.S. Stem Cell, Inc.
L.37 Vericel Corporation
M. APPENDIX
N. GLOSSARY OF TERMS
B. INTRODUCTION TO STEM CELLS
B.1 What are Stem Cells?
B.2 Categories of Stem Cells
B.2.1 Totipotent Stem Cells
B.2.2 Multipotent Stem Cells
B.2.3 Pluripotent Stem Cells
B.3 Where do Stem Cells Come From?
B.4 Importance of Stem Cells
B.5 Stem Cell Research vs. Cloning
C. LOOKING INTO STEM CELL RESEARCH
C.1 Embryonic Stem Cell Research
C.2 Adult Stem Cell Research
C.3 Limitation of Stem Cell Therapies by Immune Rejection
D. POTENTIAL OF STEM CELL RESEARCH & THERAPIES
D.1 ES Cells for Tissue Repair
D.2 Generic ES Cell
D.3 Adult Stem Cell Therapies
D.4 Therapeutic Cloning
E. BENEFITS OF STEM CELL THERAPIES
F. BARRIERS & CHALLENGES IN STEM CELL RESEARCH
F.1 Ethical Issues
F.2 Moral Issues
F.3 Issues Surrounding Embryo Destruction
F.4 Issues Surrounding Cloning
F.5 Funding & Economic Issues
F.6 Intellectual Property Challenges
F.7 Justice Issues
F.8 Lack of Accountability
F.9 Private Sector Lapses
F.10 Public Sector Lapses
F.11 Religious Issues
G. STEM CELL IN MEDICAL USE
G.1 Blood Disorders
G.2 Cancer
G.3 Diseases of Bone and Cartilage
G.4 Nervous System Diseases
G.5 Primary Immunodeficiency Diseases
G.6 Toxicity and Drug Testing
G.7 Transplantable Organs
G.8 Type 1 Diabetes in Children
H. TRENDS IN THE INDUSTRY
H.1 Variations in the Source of Stem Cells
H.2 Application in the Pharmaceutical Industry
H.3 Creation of Human-Animal Hybrid Embryos
H.4 Stem Cells for the Treatment of Heart Disease
I. FUNDING FOR STEM CELL RESEARCH
I.1 History of Embryo Research Funding
I.2 US Politics and the Stem Cells Industry
I.3 Moral Issues Affecting the Policy
I.4 Significance & Requirement of Federal Funding
I.5 Implementing the Current Policy
I.6 Conclusion
J. GLOBAL APPROACH TO HUMAN STEM CELL RESEARCH
J.1 Australia
J.2 European Union
J.3 United Kingdom
J.4 United States
J.5 Canada
J.6 China
J.7 Germany
J.8 Israel
J.9 Japan
K. INDUSTRY OUTLOOK
L. LEADING PLAYERS IN STEM CELL RESEARCH
L.1 AlloSource, Inc.
L.2 Amgen
L.3 Anterogen
L.4 Apceth Biopharma
L.5 Astellas Pharma
L.6 Athersys
L.7 Biomagnetics Diagnostics Corporation
L.8 BioTime, Inc.
L.9 BrainStorm Cell Therapeutics
L.10 Caladrius Biosciences Inc
L.11 Celyad SA
L.12 Cesca Therapeutics
L.13 Cryo-Cell International
L.14 Cynata Therapeutics Limited
L.15 CytoGenix, Inc.
L.16 Cytori Therapeutics Inc
L.17 Gamida Cell Ltd.
L.18 Geron Corporation
L.19 International Stem Cell Corporation (ISCO)
L.20 Medipost
L.21 Mesoblast Limited
L.22 Microbot Medical Inc.
L.23 Microchip Technology Inc.
L.24 Neuralstem Inc.
L.25 Neuralstem, Inc.
L.26 Osiris Therapeutics, Inc.
L.27 Pharmicell Inc.
L.28 Pluristem Therapeutics
L.29 Quest Diagnostics
L.30 Regeneus Ltd
L.31 Reliance Life Sciences
L.32 ReNeuron
L.33 Stempeutics Research
L.34 Tigenix NV
L.35 Transition Therapeutics Inc.
L.36 U.S. Stem Cell, Inc.
L.37 Vericel Corporation
M. APPENDIX
N. GLOSSARY OF TERMS
